Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth
Aditya Birla Sun Life Mutual Fund
NAV
₹36.4100
as of 31 Jul 2026
Expense Ratio
2.30%
AUM
₹932 Cr
Lumpsum returns (CAGR)
- 1Y
- +14.53%
- 3Y
- +20.95%
- 5Y
- +13.49%
- Since Inception
- +20.09%
SIP returns (XIRR)
- 1Y
- +29.54%
- 3Y
- +18.25%
- 5Y
- +18.68%
- Since Inception
- +18.76%
What history actually did — last 7 years (Aug 2019 – Jul 2026)
A ₹5,000 monthly SIP for the last 7 years (Aug 2019 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹7,90,493 today — ₹4,15,000 invested, 18.4% XIRR.
₹4,15,000
Invested
₹7,90,493
Value today
18.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 7 years (Aug 2019 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 7 years ago would be ₹3,61,569 today (20.2% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2019 would still hold ₹28,25,197.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹7,90,493 in this fund vs ₹6,83,493 in the benchmark — outperformance of ₹1,07,000.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 7 years (Aug 2019 – Jul 2026) (22 Mar 2020) would be ₹3,92,349 today (3.92×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.59
Sharpe Ratio
+0.12
Alpha
0.20
Beta
0.55
Sortino
13.36%
Std Dev
-8.99%
Max Drawdown
Performance Comparison
Thinking about Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Limited12.09%
- 2Apollo Hospitals Enterprise Limited7.30%
- 3J.B. Chemicals & Pharmaceuticals Limited4.71%
- 4Torrent Pharmaceuticals Limited4.68%
- 5Aurobindo Pharma Limited4.55%
- 6Ajanta Pharmaceuticals Limited4.38%
- 7Mankind Pharma Ltd3.92%
- 8Lupin Limited3.74%
- 9Sai Life Sciences Ltd3.50%
- 10Abbott India Limited3.26%
Investment Objective
Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Aditya Birla Sun Life Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹932 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare. The current expense ratio is 2.30%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations